Pasithea Therapeutics Corp.
KTTA
$1.19
-$0.02-1.65%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.00M | -3.87M | -3.86M | -5.05M | -3.61M |
| Total Depreciation and Amortization | 162.30K | 162.30K | 162.30K | 162.30K | 162.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 218.20K | 196.60K | 319.80K | -472.00K | 665.80K |
| Change in Net Operating Assets | -501.10K | -531.40K | -942.30K | 1.45M | 129.90K |
| Cash from Operations | -3.12M | -4.04M | -4.32M | -3.91M | -2.65M |
| Capital Expenditure | -- | -- | -- | 0.00 | 22.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 54.50K | 27.50K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 594.40K | -594.40K |
| Cash from Investing | -- | -- | -- | 648.90K | -544.20K |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | 0.00 | -133.30K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -3.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 4.54M | -- | -- | -- | -- |
| Cash from Financing | 4.54M | -- | -- | 0.00 | -3.86M |
| Foreign Exchange rate Adjustments | -27.10K | -2.90K | -600.00 | 3.10K | -4.30K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.39M | -4.04M | -4.32M | -3.25M | -7.06M |
